Vector-borne diseases (VBDs) represent a significant public health issue in India, with cases escalating in recent years. This article aims to provide healthcare professionals with a comprehensive understanding of this growing threat.
In India, VBDs such as malaria, dengue, and chikungunya are prevalent, with the country shouldering a significant portion of the global burden. The incidence of these diseases has increased due to various factors, including climate change, urbanization, and population growth.
Climate change has created favorable conditions for vector proliferation and survival, thereby increasing the transmission of VBDs. Rising temperatures and altered rainfall patterns have extended the breeding season of vectors, leading to more frequent outbreaks.
Rapid urbanization and population growth have led to overcrowded living conditions, inadequate sanitation, and stagnant water bodies, providing ideal breeding grounds for vectors. These conditions, coupled with limited healthcare infrastructure, have exacerbated the VBD problem.
Controlling VBDs in India faces multiple challenges, including inadequate surveillance, resistance to insecticides, and limited access to healthcare services. Furthermore, the lack of public awareness about preventive measures contributes to the persistence of these diseases.
Healthcare professionals play a crucial role in combating VBDs. They are at the forefront of diagnosing, treating, and managing these diseases. Moreover, they can contribute to raising awareness about preventative measures and advocating for improved public health policies.
Addressing the rising threat of VBDs in India requires a multi-faceted approach, involving improved surveillance, public education, and strengthening of healthcare infrastructure. Healthcare professionals, with their expertise and influence, are well-positioned to lead this fight against VBDs, thereby safeguarding public health.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation